Citation Impact
Citing Papers
Exogenous Hsp70 delays senescence and improves cognitive function in aging mice
2015
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
2007 StandoutScienceNobel
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion
2008 StandoutNobel
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3 + CD25 + CD4 + regulatory T cells
2005 StandoutNobel
The urgent need to recover MHC class I in cancers for effective immunotherapy
2016
Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
2014 Science
Combinatorial Cancer Immunotherapy
2006
mRNA-based dendritic cell vaccines
2014
Is autoimmunity the Achilles' heel of cancer immunotherapy?
2017
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome
2007 StandoutNobel
Imaging in the era of molecular oncology
2008 StandoutNature
Hallmarks of aging: An expanding universe
2023 Standout
The Human T Cell Response to Melanoma Antigens
2006
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
2013
Dendritic cells: versatile controllers of the immune system
2007 StandoutNobel
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
A listing of human tumor antigens recognized by T cells
2001
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen
2006
Immunology and immunotherapy of colorectal cancer
2003
Control of Immune Responses by Antigen-Specific Regulatory T Cells Expressing the Folate Receptor
2007 StandoutNobel
Towards patient‐specific tumor antigen selection for vaccination
2002
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
2014
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
2005 StandoutNobel
A listing of human tumor antigens recognized by T cells: March 2004 update
2004
Sources of diversity in T cell epitope discovery
2011
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Regulatory T cells in immune surveillance and treatment of cancer
2006 StandoutNobel
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
2011
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
2016 Standout
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient
2011
Cancer vaccines: between the idea and the reality
2003
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
2012 Nature
Antigens for cancer immunotherapy
2008
In vivo antigen delivery by aSalmonella typhimurium type III secretion system for therapeutic cancer vaccines
2006
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Autologous tumor vaccines processed to express ?-gal epitopes: a practical approach to immunotherapy in cancer
2004
Cancer immunotherapy comes of age
2011 StandoutNature
Therapeutic vaccines for cancer: an overview of clinical trials
2014
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Autoimmunity and tumor immunity induced by immune responses to mutations in self
2006
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity
2014
Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
2013
Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells
2007 StandoutNobel
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM
2005
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
2012 StandoutNobel
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Human Tumor Antigens and Cancer Immunotherapy
2015
HLA-Binding Properties of Tumor Neoepitopes in Humans
2014
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
2016
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
2008 StandoutNobel
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional Tolerance
2004
Chimeric Antigen Receptor Therapy
2018 Standout
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
2004 StandoutNobel
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
2014 StandoutScienceNobel
HUMAN T CELL RESPONSES AGAINST MELANOMA
2005
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Neoantigens in cancer immunotherapy
2015 StandoutScience
Promoter-Dependent Mechanism Leading to Selective Hypomethylation within the 5′ Region of Gene MAGE-A1 in Tumor Cells
2004
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
The α‐gal epitope and the anti‐Gal antibody in xenotransplantation and in cancer immunotherapy
2005
Dendritic Cell Surface Calreticulin Is a Receptor for NY-ESO-1: Direct Interactions between Tumor-Associated Antigen and the Innate Immune System
2006
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
CELL BIOLOGY OF ANTIGEN PROCESSING IN VITRO AND IN VIVO
2005
Works of Jacques Chapiro being referenced
Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases
2011
An Antigenic Peptide Produced by Peptide Splicing in the Proteasome
2004 Science
Tumor‐specific shared antigenic peptides recognized by human T cells
2002
A MAGE‐C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy
2011
Production of an antigenic peptide by insulin-degrading enzyme
2010
The Production of a New MAGE-3 Peptide Presented to Cytolytic T Lymphocytes by HLA-B40 Requires the Immunoproteasome
2002
Analysis of the Processing of Seven Human Tumor Antigens by Intermediate Proteasomes
2012
Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation
2006
Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules
2010